Literature DB >> 19617712

Ubiquitination of HEXIM1 by HDM2.

Joanne Lau1, Qiao Jing Lew, Gaelle Diribarne, Annemieke A Michels, Anwesha Dey, Olivier Bensaude, David P Lane, Sheng-Hao Chao.   

Abstract

Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is an inhibitor of the positive transcription elongation factor b (P-TEFb), which controls RNA polymerase II transcription and human immunodeficiency virus Tat transactivation. In cells, more than half of P-TEFb is associated with HEXIM1 resulting in the inactivation of P-TEFb. Recently, we found that nucleophosmin (NPM), a key factor involved in p53 signaling pathway, interacts with HEXIM1 and activates P-TEFb-dependent transcription. Here we report that human double minute-2 protein (HDM2), a p53-specific E3 ubiquitin ligase, specifically ubiquitinates HEXIM1 through the lysine residues located within the basic region of HEXIM1. However, the HDM2-induced HEXIM1 ubiquitination does not lead to proteasome-mediated protein degradation. Fusion of ubiquitin to HEXIM1 demonstrates stronger inhibition on P-TEFb-dependent transcription. Our results demonstrate that HDM2 functions as a specific E3 ubiquitin ligase for HEXIM1, suggesting a possible role for HEXIM1 ubiquitination in the regulation of P-TEFb activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617712     DOI: 10.4161/cc.8.14.9015

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

Review 1.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

2.  The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

Authors:  Tyler B Faust; Yang Li; Curtis W Bacon; Gwendolyn M Jang; Amit Weiss; Bhargavi Jayaraman; Billy W Newton; Nevan J Krogan; Iván D'Orso; Alan D Frankel
Journal:  Elife       Date:  2018-05-30       Impact factor: 8.140

Review 3.  CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

Authors:  Sungyoo Cho; Sebastian Schroeder; Melanie Ott
Journal:  Cell Cycle       Date:  2010-05-29       Impact factor: 4.534

4.  Identification of HEXIM1 as a positive regulator of p53.

Authors:  Qiao Jing Lew; Yi Ling Chia; Kai Ling Chu; Yuen Ting Lam; Meera Gurumurthy; Shengli Xu; Kong Peng Lam; Nge Cheong; Sheng-Hao Chao
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

5.  Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Authors:  Jackson R Taylor; Brian D Lehmann; William H Chappell; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2011-08

6.  HEXIM1, a New Player in the p53 Pathway.

Authors:  Qiao Jing Lew; Kai Ling Chu; Yi Ling Chia; Nge Cheong; Sheng-Hao Chao
Journal:  Cancers (Basel)       Date:  2013-07-04       Impact factor: 6.639

7.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

8.  HEXIM1 induces differentiation of human pluripotent stem cells.

Authors:  Vanessa Ding; Qiao Jing Lew; Kai Ling Chu; Subaashini Natarajan; Vikneswari Rajasegaran; Meera Gurumurthy; Andre B H Choo; Sheng-Hao Chao
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

Review 9.  Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.

Authors:  Ruichuan Chen; Jasper H N Yik; Qiao Jing Lew; Sheng-Hao Chao
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

10.  Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.

Authors:  Shu Hui Neo; Qiao Jing Lew; Ser Mei Koh; Lu Zheng; Xuezhi Bi; Sheng-Hao Chao
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.